DatasetName,GRAMD1A_S(260) GRAMD1A_S(263) GRAMD1A_S(267) GRAMD1A_S(281) GRAMD1A_S(354) GRAMD1A_S(560) GRAMD1A_S(586) GRAMD1A_S(72) GRAMD1A_T(12) GRAMD1A_T(270) GRAMD1A_T(277),GRAMD1A_S(10) GRAMD1A_S(11) GRAMD1A_S(142) GRAMD1A_S(368) GRAMD1A_S(577) GRAMD1A_T(364) GRAMD1A_T(403) GRAMD1A_T(57),GRAMD1A_S(16) GRAMD1A_S(1612) GRAMD1A_S(18) GRAMD1A_S(256) GRAMD1A_S(262) GRAMD1A_S(350) GRAMD1A_S(358) GRAMD1A_S(393) GRAMD1A_S(550)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,,
FSO2013_Ratio M/L normalized Rep3,0.4600164030358227,,0.42948504927216413
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,0.4986877741113384,,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,,
ZX2022_Control Replicate 2,,,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,,,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,0.5212307996620171,,0.4284729976002034
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,0.4899737854039483,,0.4066620045905836
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,0.4851611939215399,,
DB2022_Intensity L2,,,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,0.5161103214092948,,0.4288099165993718
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,,,
RB2022_5_PreEndurance,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,0.5091135638008011,0.5526449792120377,0.479151627127918
WZ2023_Pu_010_30min,0.47995046403480673,,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,,,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,0.4899568119363183,,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,0.4863776934694943,,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,0.47602445754840245,,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,0.5006772664372858,,
RB2022_5_PreSprint,,,
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,,
FSO2013_Ratio H/L normalized Rep2___2,0.5100930506097858,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.47688014189003314,0.5750962175656471,0.3754558003935353
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,,,
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,0.48070830065842574,,0.40356664434696177
RB2022_2_PreSprint,,,
ZX2022_CB treated Replicate 3,,,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,0.46622371425030573,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,0.4847202372101414,,
WZ2023_Pu_005_10min,0.47673465452898345,,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,0.4970669099289457,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,0.4790612749654647,,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,,,
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,,,
EJN2021_3_Rest_Basal,0.48949028043450854,,
CR2017_Ratio Replicate 1.3,,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,0.482903541019882,,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,0.5264409184770475,,
AH2018_LFQ_1_C,0.49431237461407834,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,0.48427933783683375,,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,0.47464838979414187,,
CK2022_11 40-1,0.4968593605469387,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,0.47955409019150125,,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,,
FSO2013_Ratio H/L normalized Rep2,0.5039061960925139,,
WZ2023_Pu_005_20min,0.48499229339014865,,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,0.48446215245178587,,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,0.4775578309128779,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,,,
DB2022_LFQ intensity L1.2,,,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,
CK2022_1 200-1,0.4826078335356939,0.5735325258134275,0.41662101299478105
PG2020_Intensity Mock_10h_D,0.45392658536424785,,
SR2019_MCF10A_Biol_repl_2,,,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,0.4715001688586345,0.605667282629085,0.42186658997317994
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,0.49234594211798727,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,,,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,,
KBE2022_Log2_Ex_8_T,0.4820246050191095,,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,,0.5790317478148346,0.4118840332314926
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,0.4981201886444396,,
CK2022_3 40-1,0.4866140000490942,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,0.4871400974130762,,
HH2022_Reporter intensity 8,,0.5673787017301114,
ZQ2022_N2,0.4890825935963832,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,0.48159447423858004,,
EJN2021_5_Rest_Basal,0.4918716482266749,,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,,
YA2020_Reporter_intensity_Normal_No.1,0.4940768880497476,,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,,,
RB2022_1_PostEndurance,,,
CR2017_Ratio Replicate 3,,,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,,
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,0.47914384855486103,,0.40250204473970086
HS2024_8_I_T3,,,
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,,
HS2024_6_PD_T3,,,
DL2023_12h-2,,,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,0.4680723680612589,,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,0.48558689004750044,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,,
KS2014_Intensity N3,,,
RB2022_4_RecoveryEndurance,,,
RB2022_5_RecoveryEndurance,,,
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,0.5008870062389854,,
FSO2013_Ratio H/M normalized Rep2,0.4947651985985418,,0.4240557646724188
RAM2015_Log2 A,0.5070111949066134,,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,
KS2014_Intensity E15_2,,,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,,,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,0.4860266712600227,,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,0.48870146041423285,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,,,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,0.5101559164104106,0.5533155489967151,0.480361467212262
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,0.48567674350674195,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,,,
AH2018_SILAC_IT_3_X,0.49262555898339305,,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,0.4933594141256848,,0.4192681379665521
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,0.5681700153685338,
SR2019_HCC1954_Biol_repl_2,,,
CK2022_14 40-1,0.4940215223954194,,
RB2022_6_PreSprint,,,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,0.49434845743983674,,
DL2023_control-1,0.4940291192039527,,
AR2021_ALG 10 μM,0.49277386121025285,0.5429181252355673,0.44118538238444943
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,0.4933013718031216,,
EJN2021_4_Rest_Ins,0.4897217422818232,,
RN2012_H05,,0.5875243802496158,0.44235334806104093
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,0.526079985874451,,0.4616182524960839
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,,,
EJN2021_1_Rest_Ins,0.48568110418232674,,
HH2022_Reporter intensity 3,,0.5817116181915505,0.42500718208135374
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,0.4959101224851747,,
JW2021_After_3,,,
GF2025_P8_Sph,0.4673823728805653,,0.39497022417972755
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,0.4822118750374964,,
CK2022_11 200-1,0.4890881283695572,0.5740277901539886,0.4264658616580772
CK2022_12 200-1,0.4901367556326947,0.57520811921155,0.4289204630186012
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,0.5742969464669923,0.42788087927546375
WZ2023_Su_010_20min,0.48176601979961425,,
AH2018_TMTMS2_2_N,0.4784290741468828,,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,0.48100730200377945,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,,
AH2018_TMTMS3_Pool,0.485818889912222,,
KS2014_Intensity N4,0.48463813658681615,,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,0.494191984707588,0.5772121743707116,0.42820886099063454
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,,,
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,0.4873747860256779,,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.48820152376727716,,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,
GF2025_P1_Adh,0.525189910011605,,0.46066162884117173
GF2025_P1_Sph,0.4967214444973965,,0.40929211163109
EJN2021_5_Ex_Basal,0.49381450195410037,,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,0.47500236631318327,,
CF2017_EOC 1,,,
CK2022_3 200-1,0.4833707958274647,0.5738986318309865,0.4166735057342224
AH2018_LFQ_IT_3_C,0.481178230834791,,
SR2019_Hs578T_Biol_repl_2,,,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,,,
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,,,
CK2022_2 40-1,0.48572733464254775,,
RB2022_1_PostSprint,,,
CK2022_4 200-1,0.4818354581935978,0.5741873013072463,0.4174932452049034
JW2021_Before_2,,,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,
AR2021_ALG 1 μM,0.48766830137312717,0.6226027045961685,0.4228736720159083
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,0.4914171446374269,,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,0.5127457626793398,,0.47044607599155186
CK2022_9 16-1,,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,0.49431573944408225,0.5770876924724864,0.42900809938568035
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,,,
FS2019_db/db3,,,
CK2022_15 40-1,0.4932795191451692,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,0.4807022500754911,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,0.48638478481557007,,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,0.4796104609524185,,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,0.48984061394793604,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,0.4819650226145395,,
AH2018_LFQ_M_1_N,0.486918554151663,,
KBE2022_Log2_Ex_27_U,0.4845110074484263,,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,0.5014252138537357,,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,,,
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,,,
YA2020_Reporter_intensity_Normal_No.4,0.4907600108533438,,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,
RN2012_L13,,0.5794230766834623,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,0.4818054712923455,,
SR2019_SKBR3_Biol_repl_3,,,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,0.5094392134504585,,0.4260635962576418
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,0.4967577998470102,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,,
HH2022_Reporter intensity 6,,0.576368822794467,0.42966439018168706
RB2022_2_RecoveryStrength,,,
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,,
AH2018_TMTMS2_3_X,0.4791514248180837,,
GF2025_P3_Adh,0.5572120613150484,,0.4641467493770974
SR2019_JIMT1_Biol_repl_2,,,
AH2018_TMTMS2_1_C,0.48205564676645146,,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,,
KBE2022_Log2_Ex_19_U,0.4861644528497695,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,,,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,0.49179334201472424,,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,0.49406957490792097,,0.41962146184352966
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,,,
RB2022_5_RecoverySprint,,,
RB2022_7_RecoverySprint,,,
YA2020_Reporter_intensity_Normal_No.3,0.49749536730484994,,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,0.4835208363227191,,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,,
HH2022_Reporter intensity 1,,0.581947258374724,
HH2022_Reporter intensity 2,,0.581445089988433,0.4270236798255716
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,0.4869190165721109,,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,0.5140959251751004,0.5947102722037787,0.4625020343531447
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,,,
CR2017_Ratio Replicate 2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,0.4499327454748418,,0.43279927049673994
AR2021_KD 72h,0.4888083660447546,0.6427518744616777,0.41948059401921484
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,0.48366148401617476,,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,0.48333384808951346,,
KBE2022_Log2_Ex_9_U,0.4882104416270737,,
AH2018_SILAC_M_3_N,,,
KBE2022_Log2_Ex_13_T,0.4824598882967128,,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,0.4937141511492541,,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,,,
RN2012_L12,,0.5669291800973572,0.4226840117399255
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,0.5456433827324993,,0.4293717389383812
JW2015_Intensity cap2,,,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,0.4958881833697156,,
RB2022_7_RecoveryEndurance,,,
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.48144761682983384,,
TM2022_S2.12h.B,,,
RN2012_L15,,0.5717362302318499,0.43070521476177587
KS2014_Intensity pY_PV3,,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,0.46548641365969234,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,0.48396638988461826,,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,,
RB2022_1_PreSprint,,,
HS2024_4_I_N1,,,
CK2022_7 200-1,0.4934035263691952,0.5792413668303538,0.4245484189208439
CK2022_5 200-1,0.4937943132937121,0.5802859774127888,0.42403599003056663
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,0.4820565782150513,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,,,
AH2018_LFQ_2_C,0.4960451822744663,,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,0.48828438730874346,,
AH2018_SILAC_3_C,,,
EJN2021_5_Rest_Ins,0.4893583100832106,,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,0.5260582699728075,,0.4278507520610406
CK2022_4 16-1,,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,0.4892039859686684,,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,0.48503070968462186,,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,0.49603140547102137,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,0.4871604262109683,,
AH2018_SILAC_IT_2_N,0.4932510248444928,,
AH2018_SILAC_IT_1_X,0.49252707320659117,,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,,,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,0.4802873941261269,,0.3928224770395538
WZ2023_Pe_025_20min,0.4708454931452861,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,0.49151734774782624,,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,0.48197296032258363,,
RN2012_H06,,0.5792331371779272,0.42282179030354594
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,0.4842707930976387,,
SR2019_HCC1419_Biol_repl_4,,,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,,,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,,,
WZ2023_Su_025_10min,0.47404781964964704,,
AH2018_LFQ_IT_4_X,,,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,0.4835731306889717,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,0.4834931505148004,0.566838175051665,0.38897304288740403
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,,,
KS2014_Intensity,0.4819866942905303,,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,,,
EP2017_Untreated R#1 normalized log2 ratio,0.5175703101744665,0.5703931996042214,0.4742971264221374
RN2012_L10,,0.5730547501280233,0.4296274679123203
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,0.4749804139170118,0.6043427249021626,0.42300539857136177
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,,
KBE2022_Log2_Ex_24_T,0.48469195318570635,,
RB2022_8_PostStrength,,,
AH2018_SILAC_IT_2_X,0.49257628658189695,,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,0.48451338056321946,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,,
CR2017_Ratio Replicate 1.1,,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,0.49473588975330096,0.5773666846949123,0.4288647699571133
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,0.47243132977931146,0.5774184461821301,0.42260504905541046
GF2025_P9_Sph,0.48052464003777123,,0.40952235113026236
CK2022_6 200-1,0.49334368078009555,0.5792527506674345,0.42421176333355654
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,0.48517473769894864,,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,,,
SR2019_HCC1954_Biol_repl_1,,,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,0.47020245943714883,0.5328888824842481,0.4237813422185904
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,0.49335215601559584,0.5796613025892384,0.424231146886136
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,,
RB2022_7_PostEndurance,,,
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.4849974386155946,0.5757807002471695,0.38405633167070014
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,0.4811558910589136,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,0.4847607423909783,,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.483955374135906,,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,,,
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,,,
KBE2022_Log2_Ex_39_U,0.4857980974552669,,
EP2017_Untreated R#3 log2 ratio,0.47125521328351516,0.5336723039696714,0.4250281057975762
RB2022_2_PostStrength,,,
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,,,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,0.48442060702889067,,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,,,
CR2017_Ratio Replicate 2.3,,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,0.5401061328056482,,0.46204697110694126
YA2020_Reporter_intensity_Normal_No.2,0.4954159259388194,,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,0.49371515871874894,,0.4408142912875072
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,0.49384568165423437,,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,0.48314290079847483,,
CK2022_2 16-1,,,
RAM2015_Log2 B,0.5068537502845367,,0.43767477599450766
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,0.500902482861802,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.4891813468733171,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,,,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,,,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,0.49262886999480676,,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,0.4764886927129501,,
AH2018_LFQ_4_N,,,
CR2017_Ratio Replicate 1.2,,,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,,,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,0.5730341866571969,0.4269395673864022
AH2018_SILAC_M_1_X,0.5002987091986523,,
RB2022_7_PreEndurance,,,
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,,
LY2019_P6+,,,
DB2022_LFQ intensity R2,,,
GF2025_P6_Adh,0.49480706520813444,,0.44610643249122695
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,0.4847280324164721,,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,,,
KS2014_Intensity C5,0.4827653758506034,,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,0.4900791426701716,,0.4399120706319446
RB2022_3_PostStrength,,,
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,0.48538669272670615,,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,,,
KS2014_Intensity E15_3,0.4826622993367542,,
GF2025_P3_Sph,0.5324433511709689,,0.4114012599129584
DB2022_LFQ intensity L2,,,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,0.4987073865348654,,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,0.48939649259285045,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,0.49325713320055425,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,,,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,,
ZQ2022_N1,0.492079921405957,,
LY2019_P6-,,,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,,
JW2015_Intensity pre2,,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,0.5612497641871378,0.42501178557619546
AH2018_LFQ_3_N,0.49009202687489056,,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,,,
KBE2022_Log2_Ex_13_U,0.48429942986432445,,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,0.49551480892586747,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,,,
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,0.4787635307807976,,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,0.4909920012510156,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,0.49333920067952236,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,0.5722573433196915,0.4283699817996632
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,,,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,0.4849070769715068,,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,0.4873790190262706,,
EP2017_Pervanadate R#3 log2 ratio,0.4759917226987289,0.5744235512965321,0.3740507171747164
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,0.49659148554695504,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,0.5774647913524991,0.4207340205244177
CK2022_6 40-1,0.4948916559142677,,
DB2022_LFQ intensity R2.1,,,
KBE2022_Log2_Ex_42_U,0.48720330806286594,,
LY2019_P3-,,,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,0.4831664426623013,,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,0.4712583708001055,,
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,0.48475795562686536,,
AST2020_Control.1,,,
JW2015_Intensity cap1,,,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,0.4738607844554739,,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,0.5080091434342268,,0.4635695821254391
RB2022_1_RecoveryStrength,,,
SR2019_HCC1954_Biol_repl_4,,,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,0.481102542591619,,
RB2022_4_PreSprint,,,
DB2022_Intensity R2,,,
AH2018_TMTMS2_Pool,0.48581229035258106,,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,,,
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,0.5006140835488946,,
LY2019_P8+,,,
RB2022_2_RecoveryEndurance,,,
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,,,
KS2014_Intensity pY_PV1,,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,,
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,0.49154167364489426,,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,0.4847471243361499,,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,,,
AH2018_LFQ_IT_1_X,0.4998369266482159,,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,,,
WZ2023_Pe_005_20min,0.4691197491575995,,
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,0.48636808884298266,,
SR2019_MCF10A_Biol_repl_4,,,
KS2014_Intensity pY_C5,,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,0.482938897000417,,
AH2018_TMTMS3_3_N,0.4859122206168011,,
SR2019_HCC1419_Biol_repl_2,,,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,0.4807316571757147,0.6091219324741841,0.4302122256863042
KBE2022_Log2_Ex_36_T,0.48344729193682306,,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,0.4802772472148716,,
KS2014_Intensity C2,,,
FSO2013_Ratio H/L normalized Rep1___2,0.4511776284783457,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,0.48817704345532625,,
CK2022_9 200-1,0.48842696284149834,0.5742830232263021,0.42620450302568913
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,0.48828381145577676,0.5740938030512819,0.42660238874414264
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,,,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,0.48020893943289505,,
ZQ2022_C3,0.5004966210728161,,
EJN2021_3_Rest_Ins,0.4912863515469255,,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,0.4863841831645136,,
FSO2013_Ratio H/M normalized Rep3___2,0.5252596223992634,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,0.5189469213931811,0.5713085107349115,0.4756846668453743
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,0.47549562261937606,,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,,
HS2024_5_I_T3,,,
KS2014_Intensity N1,,,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,0.5909495707338306,0.4392497535705804
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,0.4815305847731637,0.5456068327871428,0.4282903817034928
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,,
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,0.4765222412375137,,
KBE2022_Log2_Ex_29_U,0.48425082894294996,,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,0.48874009924153783,,
AH2018_LFQ_IT_4_N,,,
CK2022_15 200-1,0.49440677883536155,0.5770909538059704,0.4289497594693635
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,0.48824071647307665,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,,
CK2022_2 200-1,0.48239296866777787,0.5737211345267454,0.41689492091755975
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,0.477119171688672,,
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,0.4917566122327422,,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.4842147805927873,0.5676126116502245,0.3901215882558737
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,0.49098754982603177,,
KBE2022_Log2_Ex_44_U,0.4821683573736176,,
WZ2023_Pe_010_20min,0.48059311650337655,,
KS2014_Intensity pY_C6,,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,,
FSO2013_Ratio H/M normalized Rep3___1,0.4320074905612129,,0.4329138042208531
AH2018_SILAC_M_3_C,,,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,0.48176787492465517,,
AH2018_SILAC_M_2_X,0.4793120018145055,,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,0.48428715099832315,,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,0.47767134435278946,,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,0.4950626495643537,,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,0.47976082624303373,,
CK2022_15 16-1,,,
CK2022_3 16-1,,,
LY2019_P4-,,,
FSO2013_Ratio H/L normalized Rep3___2,0.5328619964442599,,
KS2014_Intensity pY_PV2,,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,0.48628919468318527,,0.42996630848620626
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,0.5162769952677876,,0.40667363816159285
CK2022_10 16-1,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,,
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,,
DB2022_Intensity R1,,,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,0.477580827802303,0.5807462084119568,0.4288994245446029
EJN2021_2_Ex_Basal,0.48720128621645764,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,,
AR2021_L41 10 μM,0.47684384167501526,0.5750767613269356,0.40923376691722235
CF2017_EOC 2,,,
RB2022_6_PostEndurance,,,
AH2018_SILAC_1_N,0.5008974782295778,,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,,,
RB2022_7_PreSprint,,,
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,,,
ZX2022_CB treated Replicate 1,,,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,,0.5819824284085423,0.4275491457380964
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,,,
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,0.4800022397193502,,
AR2021_L41 1 μM,0.48255824803036923,0.5286004135795422,0.42884363795728175
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,0.47872930262961955,,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,,
KS2014_Intensity C4,0.46861459303014624,,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,0.4831609386221949,,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,0.4961853641949427,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,0.4934817230093587,,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,,,
AH2018_SILAC_IT_3_C,0.4912832035464518,,
WZ2023_Pu_025_10min,0.47394336681830934,,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,0.4665974966329243,,0.4294171990482528
SR2019_JIMT1_Biol_repl_4,,,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,0.4760088152539517,,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,0.4822265517062595,,
KS2014_Intensity C6,0.4794061363117439,,
ZQ2022_N3,0.4852477795581222,,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,0.49800840950181935,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,0.4936137841701898,,
AH2018_SILAC_IT_2_C,0.4913712233994723,,
CK2022_5 40-1,0.4947072633342223,,
AH2018_LFQ_3_X,0.48813842014815134,,
UK2020_UA_3,,,
LY2019_P7-,,,
GF2025_P5_Adh,0.5539810676760123,,0.46227165010429494
RB2022_1_PostStrength,,,
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,0.4532271902716417,,
SR2019_HCC1954_Biol_repl_3,,,
CR2017_Ratio Replicate 2.2,,,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,,
ZQ2022_C1,0.4960151175434298,,
CR2017_Ratio Replicate 2.1,,,
PG2020_Intensity CT_B,0.4657903001338131,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,0.49396839042500656,,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,0.4932362301988423,,
YA2020_Reporter_intensity_Cancer_No.4,0.4921230115966042,,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,0.5212294937806063,,0.4037616083227031
RB2022_2_PreEndurance,,,
JW2021_Before_1,,,
KBE2022_Log2_Ex_25_T,0.48959345220974754,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,0.4858782995508589,,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,,,
FSO2013_Ratio H/M normalized Rep1___2,0.4514129407929328,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,
EP2017_Mitotic R#2 log2 ratio,0.4763084735916552,0.6107330123036243,0.4277444974253157
AH2018_TMTMS2_1_X,0.4787273991284518,,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.48961525729050254,,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,0.4998150584181981,,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,0.4848080492627887,,
CF2017_FTE 14,,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,,,
KBE2022_Log2_Ex_14_T,0.48477178362916895,,
EP2017_Untreated R#2 normalized log2 ratio,0.5130861278020219,0.5934467605865528,0.4612904323234128
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,,
LY2019_P5+,,,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,0.48396968293224846,0.5750277194502625,0.38268624168076176
AS2011_Ratio H/L Normalized RNAi_2_1,,,
